{"transactions":[{"id":4627009,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":18764,"kind":"person","name":"Morrell Martha","position":1,"cik":"0001855616","reported_name":"Morrell Martha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2026-09-25T20:31:37.000Z","date":"2026-09-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":335,"price":13.97,"value":4679.95,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares withheld by the Issuer on September 24, 2026 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the number of shares withheld by the Issuer on September 24, 2026 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award."}],"balance_after":51357,"source":{"system":"sec-edgar","filing":"0001855616-26-000024","document":"wk-form4_1790368295.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855616/000185561626000024/wk-form4_1790368295.xml","form_type":"4"}},{"id":673075,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":18764,"kind":"person","name":"Morrell Martha","position":1,"cik":"0001855616","reported_name":"Morrell Martha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2026-08-28T17:03:07.000Z","date":"2026-08-27","kind":"tax_withholding","planned":false,"acquired":false,"shares":358,"price":14.13,"value":5058.54,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares withheld by the Issuer on August 27, 2026 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the number of shares withheld by the Issuer on August 27, 2026 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award."}],"balance_after":51692,"source":{"system":"sec-edgar","filing":"0001855616-26-000022","document":"wk-form4_1787950985.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855616/000185561626000022/wk-form4_1787950985.xml","form_type":"4"}},{"id":726543,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":18764,"kind":"person","name":"Morrell Martha","position":1,"cik":"0001855616","reported_name":"Morrell Martha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2026-06-25T20:12:02.000Z","date":"2026-06-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":335,"price":16.22,"value":5433.7,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares withheld by the Issuer on June 24, 2026 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the number of shares withheld by the Issuer on June 24, 2026 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award."}],"balance_after":52050,"source":{"system":"sec-edgar","filing":"0001855616-26-000019","document":"wk-form4_1782418320.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855616/000185561626000019/wk-form4_1782418320.xml","form_type":"4"}},{"id":760333,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":18764,"kind":"person","name":"Morrell Martha","position":1,"cik":"0001855616","reported_name":"Morrell Martha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2026-05-28T20:40:37.000Z","date":"2026-05-27","kind":"tax_withholding","planned":false,"acquired":false,"shares":358,"price":17.06,"value":6107.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares withheld by the Issuer on May 27, 2026 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the number of shares withheld by the Issuer on May 27, 2026 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award."}],"balance_after":52385,"source":{"system":"sec-edgar","filing":"0001855616-26-000017","document":"wk-form4_1780000834.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855616/000185561626000017/wk-form4_1780000834.xml","form_type":"4"}},{"id":772323,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":18764,"kind":"person","name":"Morrell Martha","position":1,"cik":"0001855616","reported_name":"Morrell Martha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-19T20:27:18.000Z","date":"2026-05-15","kind":"grant","planned":false,"acquired":true,"shares":14550,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to the option vest on May 15, 2027. The remaining shares subject to the option vest in thirty six (36) equal consecutive monthly installments thereafter."}],"balance_after":14550,"derivative":{"exercise_price":15.36,"expiration_date":"2036-05-14","underlying":"Common Stock","underlying_shares":14550},"source":{"system":"sec-edgar","filing":"0001855616-26-000015","document":"wk-form4_1779222436.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1855616/000185561626000015/wk-form4_1779222436.xml","form_type":"4"}},{"id":772322,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":18764,"kind":"person","name":"Morrell Martha","position":1,"cik":"0001855616","reported_name":"Morrell Martha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2026-05-19T20:27:18.000Z","date":"2026-05-15","kind":"grant","planned":false,"acquired":true,"shares":5460,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each share is represented by a restricted stock unit (\"RSU\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. 25% of the RSUs vest on May 15, 2027 and the remaining RSUs vest in twelve (12) equal quarterly installments thereafter."}],"balance_after":52743,"source":{"system":"sec-edgar","filing":"0001855616-26-000015","document":"wk-form4_1779222436.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855616/000185561626000015/wk-form4_1779222436.xml","form_type":"4"}},{"id":828294,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":18764,"kind":"person","name":"Morrell Martha","position":1,"cik":"0001855616","reported_name":"Morrell Martha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2026-03-25T20:20:49.000Z","date":"2026-03-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":1341,"price":13.27,"value":17795.07,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares withheld by the Issuer on March 24, 2026 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the number of shares withheld by the Issuer on March 24, 2026 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award."}],"balance_after":47283,"source":{"system":"sec-edgar","filing":"0001855616-26-000011","document":"wk-form4_1774470047.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855616/000185561626000011/wk-form4_1774470047.xml","form_type":"4"}},{"id":861915,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":18764,"kind":"person","name":"Morrell Martha","position":1,"cik":"0001855616","reported_name":"Morrell Martha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2026-03-04T21:43:28.000Z","date":"2026-03-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":1340,"price":13.83,"value":18532.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents the number of shares withheld by the Issuer on March 3, 2026 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award."}],"balance_after":48624,"source":{"system":"sec-edgar","filing":"0001855616-26-000007","document":"wk-form4_1772660606.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1855616/000185561626000007/wk-form4_1772660606.xml","form_type":"4"}},{"id":861914,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":18764,"kind":"person","name":"Morrell Martha","position":1,"cik":"0001855616","reported_name":"Morrell Martha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2026-03-04T21:43:28.000Z","date":"2025-12-15","kind":"sale","planned":false,"acquired":false,"shares":25000,"price":15.97,"value":399250.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.83 to $16.26, inclusive. The reporting person undertakes to\nprovide the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form."}],"balance_after":49964,"source":{"system":"sec-edgar","filing":"0001855616-26-000007","document":"wk-form4_1772660606.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855616/000185561626000007/wk-form4_1772660606.xml","form_type":"4"}},{"id":874437,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":18764,"kind":"person","name":"Morrell Martha","position":1,"cik":"0001855616","reported_name":"Morrell Martha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2026-03-02T17:51:28.000Z","date":"2026-02-27","kind":"tax_withholding","planned":false,"acquired":false,"shares":358,"price":14.58,"value":5219.64,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares withheld by the Issuer on February 27, 2026 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the number of shares withheld by the Issuer on February 27, 2026 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award."}],"balance_after":74964,"source":{"system":"sec-edgar","filing":"0001855616-26-000005","document":"wk-form4_1772473884.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855616/000185561626000005/wk-form4_1772473884.xml","form_type":"4"}},{"id":888231,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":18764,"kind":"person","name":"Morrell Martha","position":1,"cik":"0001855616","reported_name":"Morrell Martha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2026-02-23T22:31:37.000Z","date":"2026-02-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":3412,"price":14.34,"value":48928.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares withheld by the Issuer on February 20, 2026 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the number of shares withheld by the Issuer on February 20, 2026 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award."}],"balance_after":75322,"source":{"system":"sec-edgar","filing":"0001855616-26-000003","document":"wk-form4_1771885895.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855616/000185561626000003/wk-form4_1771885895.xml","form_type":"4"}},{"id":980413,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":18764,"kind":"person","name":"Morrell Martha","position":1,"cik":"0001855616","reported_name":"Morrell Martha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2025-12-04T21:30:07.000Z","date":"2025-12-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":1338,"price":16.66,"value":22291.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares withheld by the Issuer on December 3, 2025 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award."}],"balance_after":78734,"source":{"system":"sec-edgar","filing":"0001855616-25-000007","document":"form4-12042025_041201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855616/000185561625000007/form4-12042025_041201.xml","form_type":"4"}},{"id":985201,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":18764,"kind":"person","name":"Morrell Martha","position":1,"cik":"0001855616","reported_name":"Morrell Martha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2025-12-01T21:15:06.000Z","date":"2025-11-27","kind":"tax_withholding","planned":false,"acquired":false,"shares":357,"price":16.5,"value":5890.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares withheld by the Issuer on November 27, 2025 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award."}],"balance_after":80072,"source":{"system":"sec-edgar","filing":"0001855616-25-000005","document":"form4-12012025_041201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855616/000185561625000005/form4-12012025_041201.xml","form_type":"4"}},{"id":990285,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":18764,"kind":"person","name":"Morrell Martha","position":1,"cik":"0001855616","reported_name":"Morrell Martha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2025-11-24T21:57:07.000Z","date":"2025-11-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":3051,"price":13.5,"value":41188.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares withheld by the Issuer on November 20, 2025 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award."}],"balance_after":80429,"source":{"system":"sec-edgar","filing":"0001855616-25-000003","document":"form4-11242025_091103.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855616/000185561625000003/form4-11242025_091103.xml","form_type":"4"}},{"id":1048089,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":18764,"kind":"person","name":"Morrell Martha","position":1,"cik":"0001855616","reported_name":"Morrell Martha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2025-09-05T00:24:01.000Z","date":"2025-09-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":1337,"price":9.36,"value":12514.32,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares withheld by the Issuer on September 3, 2025 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award."}],"balance_after":83480,"source":{"system":"sec-edgar","filing":"0001415889-25-023763","document":"form4-09052025_120957.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855616/000141588925023763/form4-09052025_120957.xml","form_type":"4"}},{"id":1053704,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":18764,"kind":"person","name":"Morrell Martha","position":1,"cik":"0001855616","reported_name":"Morrell Martha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2025-08-28T20:15:08.000Z","date":"2025-08-27","kind":"tax_withholding","planned":false,"acquired":false,"shares":357,"price":8.88,"value":3170.16,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares withheld by the Issuer on August 27, 2025 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award."}],"balance_after":84817,"source":{"system":"sec-edgar","filing":"0001415889-25-023213","document":"form4-08282025_040805.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855616/000141588925023213/form4-08282025_040805.xml","form_type":"4"}},{"id":1058338,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":18764,"kind":"person","name":"Morrell Martha","position":1,"cik":"0001855616","reported_name":"Morrell Martha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2025-08-22T20:15:05.000Z","date":"2025-08-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":3052,"price":8.66,"value":26430.32,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares withheld by the Issuer on August 20, 2025 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2,283 shares acquired pursuant to the NeuroPace, Inc. 2021 Employee Stock Purchase Plan."}],"balance_after":85174,"source":{"system":"sec-edgar","filing":"0001415889-25-022748","document":"form4-08222025_040801.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855616/000141588925022748/form4-08222025_040801.xml","form_type":"4"}},{"id":1119895,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":18764,"kind":"person","name":"Morrell Martha","position":1,"cik":"0001855616","reported_name":"Morrell Martha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2025-06-06T23:15:05.000Z","date":"2025-06-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":1338,"price":13.54,"value":18116.52,"ownership":{"direct":true},"balance_after":85943,"source":{"system":"sec-edgar","filing":"0001415889-25-016077","document":"form4-06062025_070601.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855616/000141588925016077/form4-06062025_070601.xml","form_type":"4"}},{"id":1130671,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":18764,"kind":"person","name":"Morrell Martha","position":1,"cik":"0001855616","reported_name":"Morrell Martha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2025-05-29T23:10:06.000Z","date":"2025-05-27","kind":"tax_withholding","planned":false,"acquired":false,"shares":357,"price":12.66,"value":4519.62,"ownership":{"direct":true},"balance_after":87281,"source":{"system":"sec-edgar","filing":"0001415889-25-014931","document":"form4-05292025_070503.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855616/000141588925014931/form4-05292025_070503.xml","form_type":"4"}},{"id":1139132,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":18764,"kind":"person","name":"Morrell Martha","position":1,"cik":"0001855616","reported_name":"Morrell Martha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2025-05-21T23:15:05.000Z","date":"2025-05-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":3051,"price":17.99,"value":54887.49,"ownership":{"direct":true},"balance_after":87638,"source":{"system":"sec-edgar","filing":"0001415889-25-014013","document":"form4-05212025_070501.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855616/000141588925014013/form4-05212025_070501.xml","form_type":"4"}},{"id":1167130,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":18764,"kind":"person","name":"Morrell Martha","position":1,"cik":"0001855616","reported_name":"Morrell Martha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2025-04-23T23:44:37.000Z","date":"2025-04-22","kind":"tax_withholding","planned":false,"acquired":false,"shares":237,"price":10.94,"value":2592.78,"ownership":{"direct":true},"balance_after":90689,"source":{"system":"sec-edgar","filing":"0001415889-25-011241","document":"form4-04232025_110434.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855616/000141588925011241/form4-04232025_110434.xml","form_type":"4"}},{"id":1193623,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":18764,"kind":"person","name":"Morrell Martha","position":1,"cik":"0001855616","reported_name":"Morrell Martha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-03-24T22:10:49.000Z","date":"2025-03-24","kind":"grant","planned":false,"acquired":true,"shares":19850,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to the option vest on March 24, 2026. The remaining shares subject to the option vest in thirty six (36) equal consecutive monthly installments thereafter."}],"balance_after":19850,"derivative":{"exercise_price":12.3,"expiration_date":"2035-03-23","underlying":"Common Stock","underlying_shares":19850},"source":{"system":"sec-edgar","filing":"0001415889-25-008864","document":"form4-03242025_100346.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1855616/000141588925008864/form4-03242025_100346.xml","form_type":"4"}},{"id":1193622,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":18764,"kind":"person","name":"Morrell Martha","position":1,"cik":"0001855616","reported_name":"Morrell Martha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2025-03-24T22:10:49.000Z","date":"2025-03-24","kind":"grant","planned":false,"acquired":true,"shares":11700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each share is represented by a restricted stock unit (\"RSU\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. 25% of the RSUs vest on March 24, 2026 and the remaining RSUs vest in twelve (12) equal quarterly installments thereafter."}],"balance_after":90926,"source":{"system":"sec-edgar","filing":"0001415889-25-008864","document":"form4-03242025_100346.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855616/000141588925008864/form4-03242025_100346.xml","form_type":"4"}},{"id":1222938,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":18764,"kind":"person","name":"Morrell Martha","position":1,"cik":"0001855616","reported_name":"Morrell Martha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2025-03-05T21:09:05.000Z","date":"2025-03-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":1337,"price":11.81,"value":15789.97,"ownership":{"direct":true},"balance_after":79226,"source":{"system":"sec-edgar","filing":"0001415889-25-006924","document":"form4-03052025_090301.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855616/000141588925006924/form4-03052025_090301.xml","form_type":"4"}},{"id":1236089,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":18764,"kind":"person","name":"Morrell Martha","position":1,"cik":"0001855616","reported_name":"Morrell Martha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2025-03-03T21:11:46.000Z","date":"2025-02-27","kind":"tax_withholding","planned":false,"acquired":false,"shares":1430,"price":12.56,"value":17960.8,"ownership":{"direct":true},"balance_after":80563,"source":{"system":"sec-edgar","filing":"0001415889-25-006142","document":"form4-03032025_090340.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855616/000141588925006142/form4-03032025_090340.xml","form_type":"4"}},{"id":1246634,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":18764,"kind":"person","name":"Morrell Martha","position":1,"cik":"0001855616","reported_name":"Morrell Martha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2025-02-25T23:52:20.000Z","date":"2025-02-21","kind":"sale","planned":false,"acquired":false,"shares":78334,"price":13.7213,"value":1074844.3142,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.25 to $14.21, inclusive. The reporting person undertakes to provide the Securities and Exchange  Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form."}],"balance_after":81993,"source":{"system":"sec-edgar","filing":"0001415889-25-005577","document":"form4-02252025_110217.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855616/000141588925005577/form4-02252025_110217.xml","form_type":"4"}},{"id":1246636,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":18764,"kind":"person","name":"Morrell Martha","position":1,"cik":"0001855616","reported_name":"Morrell Martha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock Option (Rt to Buy)","published_at":"2025-02-25T23:51:01.000Z","date":"2024-02-12","kind":"exercise","planned":false,"acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/48th of the shares subject to the option vest in equal monthly installments commencing September 19, 2020. If, at the time of the initial public offering, less than 232,371 of the shares subject to this option remain unvested, an amount of shares subject to this option\nshall vest and become immediately exercisable immediately prior to the offering such that a total of 232,371 shares subject to this option will be vested and immediately exercisable, subject to Dr. Morrells continued service with NeuroPace, Inc. Following such acceleration, the remaining unvested shares subject to this option will continue to vest in equal monthly installments over 48 months."}],"balance_after":140449,"derivative":{"exercise_price":0.026,"expiration_date":"2030-10-29","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001415889-25-005576","document":"form4-02252025_110255.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1855616/000141588925005576/form4-02252025_110255.xml","form_type":"4"}},{"id":1246635,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":18764,"kind":"person","name":"Morrell Martha","position":1,"cik":"0001855616","reported_name":"Morrell Martha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2025-02-25T23:51:01.000Z","date":"2024-02-12","kind":"exercise","planned":false,"acquired":true,"shares":50000,"price":0.026,"value":1300.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 13,847 shares acquired pursuant to the NeuroPace, Inc. 2021 Employee Stock Purchase Plan between April 22, 2021 and June 7, 2024."}],"balance_after":160327,"source":{"system":"sec-edgar","filing":"0001415889-25-005576","document":"form4-02252025_110255.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855616/000141588925005576/form4-02252025_110255.xml","form_type":"4"}},{"id":1246633,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":18764,"kind":"person","name":"Morrell Martha","position":1,"cik":"0001855616","reported_name":"Morrell Martha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock Option (Rt to Buy)","published_at":"2025-02-25T23:31:48.000Z","date":"2024-01-31","kind":"exercise","planned":false,"acquired":false,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"1/48th of the shares subject to the option vest in equal monthly installments commencing February 1, 2017."}],"balance_after":180449,"derivative":{"exercise_price":0.026,"expiration_date":"2030-11-30","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001415889-25-005571","document":"form4-02252025_110243.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":35,"url":"https://www.sec.gov/Archives/edgar/data/1855616/000141588925005571/form4-02252025_110243.xml","form_type":"4"}},{"id":1246632,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":18764,"kind":"person","name":"Morrell Martha","position":1,"cik":"0001855616","reported_name":"Morrell Martha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock Option (Rt to Buy)","published_at":"2025-02-25T23:31:48.000Z","date":"2024-01-31","kind":"exercise","planned":false,"acquired":false,"shares":12234,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"1/48th of the shares subject to the option vest in equal monthly installments commencing February 1, 2017."}],"balance_after":12234,"derivative":{"exercise_price":0.026,"expiration_date":"2030-11-30","underlying":"Common Stock","underlying_shares":12234},"source":{"system":"sec-edgar","filing":"0001415889-25-005571","document":"form4-02252025_110243.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":34,"url":"https://www.sec.gov/Archives/edgar/data/1855616/000141588925005571/form4-02252025_110243.xml","form_type":"4"}},{"id":1246631,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":18764,"kind":"person","name":"Morrell Martha","position":1,"cik":"0001855616","reported_name":"Morrell Martha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock Option (Rt to Buy)","published_at":"2025-02-25T23:31:48.000Z","date":"2024-01-31","kind":"exercise","planned":false,"acquired":false,"shares":192,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the shares subject to the option vest on July 1, 2012; 1/48th of the shares subject to the option vest in 36 equal monthly installments thereafter."}],"balance_after":192,"derivative":{"exercise_price":0.026,"expiration_date":"2030-11-30","underlying":"Common Stock","underlying_shares":192},"source":{"system":"sec-edgar","filing":"0001415889-25-005571","document":"form4-02252025_110243.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":33,"url":"https://www.sec.gov/Archives/edgar/data/1855616/000141588925005571/form4-02252025_110243.xml","form_type":"4"}},{"id":1246630,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":18764,"kind":"person","name":"Morrell Martha","position":1,"cik":"0001855616","reported_name":"Morrell Martha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock Option (Rt to Buy)","published_at":"2025-02-25T23:31:48.000Z","date":"2024-01-31","kind":"exercise","planned":false,"acquired":false,"shares":192,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares subject to the option vest on July 1, 2013; 1/48th of the shares subject to the option vest in 36 equal monthly installments thereafter."}],"balance_after":0,"derivative":{"exercise_price":0.026,"expiration_date":"2030-11-30","underlying":"Common Stock","underlying_shares":192},"source":{"system":"sec-edgar","filing":"0001415889-25-005571","document":"form4-02252025_110243.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":32,"url":"https://www.sec.gov/Archives/edgar/data/1855616/000141588925005571/form4-02252025_110243.xml","form_type":"4"}},{"id":1246629,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":18764,"kind":"person","name":"Morrell Martha","position":1,"cik":"0001855616","reported_name":"Morrell Martha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock Option (Rt to Buy)","published_at":"2025-02-25T23:31:48.000Z","date":"2024-01-31","kind":"exercise","planned":false,"acquired":false,"shares":192,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option vest on July 1, 2015; 1/48th of the shares subject to the option vest in 36 equal monthly installments thereafter."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"25% of the shares subject to the option vest on July 1, 2015; 1/48th of the shares subject to the option vest in 36 equal monthly installments thereafter."}],"balance_after":0,"derivative":{"exercise_price":0.026,"expiration_date":"2030-11-30","underlying":"Common Stock","underlying_shares":192},"source":{"system":"sec-edgar","filing":"0001415889-25-005571","document":"form4-02252025_110243.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":31,"url":"https://www.sec.gov/Archives/edgar/data/1855616/000141588925005571/form4-02252025_110243.xml","form_type":"4"}},{"id":1246628,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":18764,"kind":"person","name":"Morrell Martha","position":1,"cik":"0001855616","reported_name":"Morrell Martha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2025-02-25T23:31:48.000Z","date":"2024-01-31","kind":"exercise","planned":false,"acquired":true,"shares":40000,"price":0.026,"value":1040.0,"ownership":{"direct":true},"balance_after":96480,"source":{"system":"sec-edgar","filing":"0001415889-25-005571","document":"form4-02252025_110243.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":30,"url":"https://www.sec.gov/Archives/edgar/data/1855616/000141588925005571/form4-02252025_110243.xml","form_type":"4"}},{"id":1246627,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":18764,"kind":"person","name":"Morrell Martha","position":1,"cik":"0001855616","reported_name":"Morrell Martha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2025-02-25T23:31:48.000Z","date":"2024-01-31","kind":"exercise","planned":false,"acquired":true,"shares":12234,"price":0.026,"value":318.084,"ownership":{"direct":true},"balance_after":56480,"source":{"system":"sec-edgar","filing":"0001415889-25-005571","document":"form4-02252025_110243.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":29,"url":"https://www.sec.gov/Archives/edgar/data/1855616/000141588925005571/form4-02252025_110243.xml","form_type":"4"}},{"id":1246626,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":18764,"kind":"person","name":"Morrell Martha","position":1,"cik":"0001855616","reported_name":"Morrell Martha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common stock","published_at":"2025-02-25T23:31:48.000Z","date":"2024-01-31","kind":"exercise","planned":false,"acquired":true,"shares":192,"price":0.026,"value":4.992,"ownership":{"direct":true},"balance_after":44246,"source":{"system":"sec-edgar","filing":"0001415889-25-005571","document":"form4-02252025_110243.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":28,"url":"https://www.sec.gov/Archives/edgar/data/1855616/000141588925005571/form4-02252025_110243.xml","form_type":"4"}},{"id":1246625,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":18764,"kind":"person","name":"Morrell Martha","position":1,"cik":"0001855616","reported_name":"Morrell Martha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2025-02-25T23:31:48.000Z","date":"2024-01-31","kind":"exercise","planned":false,"acquired":true,"shares":192,"price":0.026,"value":4.992,"ownership":{"direct":true},"balance_after":44054,"source":{"system":"sec-edgar","filing":"0001415889-25-005571","document":"form4-02252025_110243.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":27,"url":"https://www.sec.gov/Archives/edgar/data/1855616/000141588925005571/form4-02252025_110243.xml","form_type":"4"}},{"id":1246624,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":18764,"kind":"person","name":"Morrell Martha","position":1,"cik":"0001855616","reported_name":"Morrell Martha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2025-02-25T23:31:48.000Z","date":"2024-01-31","kind":"exercise","planned":false,"acquired":true,"shares":192,"price":0.026,"value":4.992,"ownership":{"direct":true},"balance_after":43862,"source":{"system":"sec-edgar","filing":"0001415889-25-005571","document":"form4-02252025_110243.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":26,"url":"https://www.sec.gov/Archives/edgar/data/1855616/000141588925005571/form4-02252025_110243.xml","form_type":"4"}},{"id":1246623,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":18764,"kind":"person","name":"Morrell Martha","position":1,"cik":"0001855616","reported_name":"Morrell Martha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2025-02-25T23:31:48.000Z","date":"2025-02-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":3405,"price":14.23,"value":48453.15,"ownership":{"direct":true},"balance_after":43670,"source":{"system":"sec-edgar","filing":"0001415889-25-005571","document":"form4-02252025_110243.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":25,"url":"https://www.sec.gov/Archives/edgar/data/1855616/000141588925005571/form4-02252025_110243.xml","form_type":"4"}},{"id":1246622,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":18764,"kind":"person","name":"Morrell Martha","position":1,"cik":"0001855616","reported_name":"Morrell Martha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2025-02-25T23:31:48.000Z","date":"2025-01-22","kind":"tax_withholding","planned":false,"acquired":false,"shares":265,"price":14.04,"value":3720.6,"ownership":{"direct":true},"balance_after":47075,"source":{"system":"sec-edgar","filing":"0001415889-25-005571","document":"form4-02252025_110243.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":24,"url":"https://www.sec.gov/Archives/edgar/data/1855616/000141588925005571/form4-02252025_110243.xml","form_type":"4"}},{"id":1246621,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":18764,"kind":"person","name":"Morrell Martha","position":1,"cik":"0001855616","reported_name":"Morrell Martha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2025-02-25T23:31:48.000Z","date":"2024-12-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":1413,"price":11.93,"value":16857.09,"ownership":{"direct":true},"balance_after":47340,"source":{"system":"sec-edgar","filing":"0001415889-25-005571","document":"form4-02252025_110243.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":23,"url":"https://www.sec.gov/Archives/edgar/data/1855616/000141588925005571/form4-02252025_110243.xml","form_type":"4"}},{"id":1246620,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":18764,"kind":"person","name":"Morrell Martha","position":1,"cik":"0001855616","reported_name":"Morrell Martha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2025-02-25T23:31:48.000Z","date":"2024-11-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":3045,"price":9.19,"value":27983.55,"ownership":{"direct":true},"balance_after":48753,"source":{"system":"sec-edgar","filing":"0001415889-25-005571","document":"form4-02252025_110243.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":22,"url":"https://www.sec.gov/Archives/edgar/data/1855616/000141588925005571/form4-02252025_110243.xml","form_type":"4"}},{"id":1246619,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":18764,"kind":"person","name":"Morrell Martha","position":1,"cik":"0001855616","reported_name":"Morrell Martha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2025-02-25T23:31:48.000Z","date":"2024-10-22","kind":"tax_withholding","planned":false,"acquired":false,"shares":237,"price":6,"value":1422.0,"ownership":{"direct":true},"balance_after":51798,"source":{"system":"sec-edgar","filing":"0001415889-25-005571","document":"form4-02252025_110243.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":21,"url":"https://www.sec.gov/Archives/edgar/data/1855616/000141588925005571/form4-02252025_110243.xml","form_type":"4"}},{"id":1246618,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":18764,"kind":"person","name":"Morrell Martha","position":1,"cik":"0001855616","reported_name":"Morrell Martha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2025-02-25T23:31:48.000Z","date":"2024-09-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":1334,"price":7.39,"value":9858.26,"ownership":{"direct":true},"balance_after":52035,"source":{"system":"sec-edgar","filing":"0001415889-25-005571","document":"form4-02252025_110243.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/1855616/000141588925005571/form4-02252025_110243.xml","form_type":"4"}},{"id":1246617,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":18764,"kind":"person","name":"Morrell Martha","position":1,"cik":"0001855616","reported_name":"Morrell Martha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2025-02-25T23:31:48.000Z","date":"2024-08-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":3045,"price":7.24,"value":22045.8,"ownership":{"direct":true},"balance_after":53369,"source":{"system":"sec-edgar","filing":"0001415889-25-005571","document":"form4-02252025_110243.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1855616/000141588925005571/form4-02252025_110243.xml","form_type":"4"}},{"id":1246616,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":18764,"kind":"person","name":"Morrell Martha","position":1,"cik":"0001855616","reported_name":"Morrell Martha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2025-02-25T23:31:48.000Z","date":"2024-07-22","kind":"tax_withholding","planned":false,"acquired":false,"shares":237,"price":7.65,"value":1813.05,"ownership":{"direct":true},"balance_after":56414,"source":{"system":"sec-edgar","filing":"0001415889-25-005571","document":"form4-02252025_110243.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1855616/000141588925005571/form4-02252025_110243.xml","form_type":"4"}},{"id":1246615,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":18764,"kind":"person","name":"Morrell Martha","position":1,"cik":"0001855616","reported_name":"Morrell Martha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2025-02-25T23:31:48.000Z","date":"2024-06-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":1335,"price":6.46,"value":8624.1,"ownership":{"direct":true},"balance_after":56511,"source":{"system":"sec-edgar","filing":"0001415889-25-005571","document":"form4-02252025_110243.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1855616/000141588925005571/form4-02252025_110243.xml","form_type":"4"}},{"id":1246614,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":18764,"kind":"person","name":"Morrell Martha","position":1,"cik":"0001855616","reported_name":"Morrell Martha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2025-02-25T23:31:48.000Z","date":"2024-05-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":3045,"price":7.98,"value":24299.1,"ownership":{"direct":true},"balance_after":57986,"source":{"system":"sec-edgar","filing":"0001415889-25-005571","document":"form4-02252025_110243.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1855616/000141588925005571/form4-02252025_110243.xml","form_type":"4"}},{"id":1246613,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":18764,"kind":"person","name":"Morrell Martha","position":1,"cik":"0001855616","reported_name":"Morrell Martha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2025-02-25T23:31:48.000Z","date":"2024-04-22","kind":"tax_withholding","planned":false,"acquired":false,"shares":237,"price":14,"value":3318.0,"ownership":{"direct":true},"balance_after":61268,"source":{"system":"sec-edgar","filing":"0001415889-25-005571","document":"form4-02252025_110243.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1855616/000141588925005571/form4-02252025_110243.xml","form_type":"4"}},{"id":1246612,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":18764,"kind":"person","name":"Morrell Martha","position":1,"cik":"0001855616","reported_name":"Morrell Martha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2025-02-25T23:31:48.000Z","date":"2024-03-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":1334,"price":15.99,"value":21330.66,"ownership":{"direct":true},"balance_after":61031,"source":{"system":"sec-edgar","filing":"0001415889-25-005571","document":"form4-02252025_110243.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1855616/000141588925005571/form4-02252025_110243.xml","form_type":"4"}},{"id":1246611,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":18764,"kind":"person","name":"Morrell Martha","position":1,"cik":"0001855616","reported_name":"Morrell Martha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2025-02-25T23:31:48.000Z","date":"2024-02-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":12474,"price":17.5,"value":218295.0,"ownership":{"direct":true},"balance_after":62602,"source":{"system":"sec-edgar","filing":"0001415889-25-005571","document":"form4-02252025_110243.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1855616/000141588925005571/form4-02252025_110243.xml","form_type":"4"}},{"id":1246610,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":18764,"kind":"person","name":"Morrell Martha","position":1,"cik":"0001855616","reported_name":"Morrell Martha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2025-02-25T23:31:48.000Z","date":"2024-01-22","kind":"tax_withholding","planned":false,"acquired":false,"shares":264,"price":14.84,"value":3917.76,"ownership":{"direct":true},"balance_after":75076,"source":{"system":"sec-edgar","filing":"0001415889-25-005571","document":"form4-02252025_110243.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1855616/000141588925005571/form4-02252025_110243.xml","form_type":"4"}},{"id":1246609,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":18764,"kind":"person","name":"Morrell Martha","position":1,"cik":"0001855616","reported_name":"Morrell Martha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2025-02-25T23:31:48.000Z","date":"2023-12-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":1303,"price":8.9,"value":11596.7,"ownership":{"direct":true},"balance_after":75340,"source":{"system":"sec-edgar","filing":"0001415889-25-005571","document":"form4-02252025_110243.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1855616/000141588925005571/form4-02252025_110243.xml","form_type":"4"}},{"id":1246608,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":18764,"kind":"person","name":"Morrell Martha","position":1,"cik":"0001855616","reported_name":"Morrell Martha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2025-02-25T23:31:48.000Z","date":"2023-10-22","kind":"tax_withholding","planned":false,"acquired":false,"shares":231,"price":6.88,"value":1589.28,"ownership":{"direct":true},"balance_after":76643,"source":{"system":"sec-edgar","filing":"0001415889-25-005571","document":"form4-02252025_110243.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1855616/000141588925005571/form4-02252025_110243.xml","form_type":"4"}},{"id":1246607,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":18764,"kind":"person","name":"Morrell Martha","position":1,"cik":"0001855616","reported_name":"Morrell Martha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2025-02-25T23:31:48.000Z","date":"2023-09-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":1302,"price":8.93,"value":11626.86,"ownership":{"direct":true},"balance_after":76874,"source":{"system":"sec-edgar","filing":"0001415889-25-005571","document":"form4-02252025_110243.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1855616/000141588925005571/form4-02252025_110243.xml","form_type":"4"}},{"id":1246606,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":18764,"kind":"person","name":"Morrell Martha","position":1,"cik":"0001855616","reported_name":"Morrell Martha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2025-02-25T23:31:48.000Z","date":"2023-07-22","kind":"tax_withholding","planned":false,"acquired":false,"shares":231,"price":4.13,"value":954.03,"ownership":{"direct":true},"balance_after":78176,"source":{"system":"sec-edgar","filing":"0001415889-25-005571","document":"form4-02252025_110243.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1855616/000141588925005571/form4-02252025_110243.xml","form_type":"4"}},{"id":1246605,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":18764,"kind":"person","name":"Morrell Martha","position":1,"cik":"0001855616","reported_name":"Morrell Martha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2025-02-25T23:31:48.000Z","date":"2023-06-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":1303,"price":4.11,"value":5355.33,"ownership":{"direct":true},"balance_after":78407,"source":{"system":"sec-edgar","filing":"0001415889-25-005571","document":"form4-02252025_110243.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1855616/000141588925005571/form4-02252025_110243.xml","form_type":"4"}},{"id":1246604,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":18764,"kind":"person","name":"Morrell Martha","position":1,"cik":"0001855616","reported_name":"Morrell Martha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2025-02-25T23:31:48.000Z","date":"2023-04-22","kind":"tax_withholding","planned":false,"acquired":false,"shares":231,"price":4.25,"value":981.75,"ownership":{"direct":true},"balance_after":79710,"source":{"system":"sec-edgar","filing":"0001415889-25-005571","document":"form4-02252025_110243.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1855616/000141588925005571/form4-02252025_110243.xml","form_type":"4"}},{"id":1246603,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":18764,"kind":"person","name":"Morrell Martha","position":1,"cik":"0001855616","reported_name":"Morrell Martha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2025-02-25T23:31:48.000Z","date":"2023-03-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":5167,"price":4.1,"value":21184.7,"ownership":{"direct":true},"balance_after":79941,"source":{"system":"sec-edgar","filing":"0001415889-25-005571","document":"form4-02252025_110243.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1855616/000141588925005571/form4-02252025_110243.xml","form_type":"4"}},{"id":1246602,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":18764,"kind":"person","name":"Morrell Martha","position":1,"cik":"0001855616","reported_name":"Morrell Martha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2025-02-25T23:31:48.000Z","date":"2023-01-22","kind":"tax_withholding","planned":false,"acquired":false,"shares":264,"price":2.98,"value":786.72,"ownership":{"direct":true},"balance_after":85108,"source":{"system":"sec-edgar","filing":"0001415889-25-005571","document":"form4-02252025_110243.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1855616/000141588925005571/form4-02252025_110243.xml","form_type":"4"}},{"id":1246601,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":18764,"kind":"person","name":"Morrell Martha","position":1,"cik":"0001855616","reported_name":"Morrell Martha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2025-02-25T23:31:48.000Z","date":"2022-10-22","kind":"tax_withholding","planned":false,"acquired":false,"shares":233,"price":3.02,"value":703.66,"ownership":{"direct":true},"balance_after":85372,"source":{"system":"sec-edgar","filing":"0001415889-25-005571","document":"form4-02252025_110243.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1855616/000141588925005571/form4-02252025_110243.xml","form_type":"4"}},{"id":1246600,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":18764,"kind":"person","name":"Morrell Martha","position":1,"cik":"0001855616","reported_name":"Morrell Martha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2025-02-25T23:31:48.000Z","date":"2022-07-22","kind":"tax_withholding","planned":false,"acquired":false,"shares":231,"price":5.55,"value":1282.05,"ownership":{"direct":true},"balance_after":85605,"source":{"system":"sec-edgar","filing":"0001415889-25-005571","document":"form4-02252025_110243.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1855616/000141588925005571/form4-02252025_110243.xml","form_type":"4"}},{"id":1246599,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":18764,"kind":"person","name":"Morrell Martha","position":1,"cik":"0001855616","reported_name":"Morrell Martha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2025-02-25T23:31:48.000Z","date":"2022-04-22","kind":"tax_withholding","planned":false,"acquired":false,"shares":926,"price":8.32,"value":7704.32,"ownership":{"direct":true},"balance_after":85836,"source":{"system":"sec-edgar","filing":"0001415889-25-005571","document":"form4-02252025_110243.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855616/000141588925005571/form4-02252025_110243.xml","form_type":"4"}},{"id":1289683,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":18764,"kind":"person","name":"Morrell Martha","position":1,"cik":"0001855616","reported_name":"Morrell Martha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2025-02-01T00:16:57.000Z","date":"2025-01-30","kind":"sale","planned":true,"acquired":false,"shares":200,"price":15,"value":3000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":86762,"source":{"system":"sec-edgar","filing":"0001415889-25-002590","document":"form4-02012025_120253.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1855616/000141588925002590/form4-02012025_120253.xml","form_type":"4"}},{"id":1289682,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":18764,"kind":"person","name":"Morrell Martha","position":1,"cik":"0001855616","reported_name":"Morrell Martha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2025-02-01T00:16:57.000Z","date":"2025-01-29","kind":"sale","planned":true,"acquired":false,"shares":100,"price":15,"value":1500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":86962,"source":{"system":"sec-edgar","filing":"0001415889-25-002590","document":"form4-02012025_120253.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855616/000141588925002590/form4-02012025_120253.xml","form_type":"4"}},{"id":1293152,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":18764,"kind":"person","name":"Morrell Martha","position":1,"cik":"0001855616","reported_name":"Morrell Martha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2025-01-28T23:08:53.000Z","date":"2025-01-24","kind":"sale","planned":true,"acquired":false,"shares":3200,"price":15.01,"value":48032.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.00 to $15.04, inclusive. The reporting person undertakes to provide the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form"}],"balance_after":87062,"source":{"system":"sec-edgar","filing":"0001415889-25-002207","document":"form4-01282025_110150.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855616/000141588925002207/form4-01282025_110150.xml","form_type":"4"}},{"id":1612616,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":18764,"kind":"person","name":"Morrell Martha","position":1,"cik":"0001855616","reported_name":"Morrell Martha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-29T01:56:33.000Z","date":"2024-02-27","kind":"grant","planned":false,"acquired":true,"shares":24950,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to the option vest on February 27, 2025. The remaining shares subject to the option vest in thirty six (36) equal consecutive monthly installments thereafter."}],"balance_after":24950,"derivative":{"exercise_price":17.11,"expiration_date":"2034-02-26","underlying":"Common Stock","underlying_shares":24950},"source":{"system":"sec-edgar","filing":"0001209191-24-004089","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1855616/000120919124004089/doc4.xml","form_type":"4"}},{"id":1612615,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":18764,"kind":"person","name":"Morrell Martha","position":1,"cik":"0001855616","reported_name":"Morrell Martha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-02-29T01:56:33.000Z","date":"2024-02-27","kind":"grant","planned":false,"acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each share is represented by a restricted stock unit (\"RSU\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. 25% of the RSUs vest on February 27, 2025 and the remaining RSUs vest in twelve (12) equal quarterly installments thereafter."}],"balance_after":90262,"source":{"system":"sec-edgar","filing":"0001209191-24-004089","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855616/000120919124004089/doc4.xml","form_type":"4"}},{"id":1656962,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":18764,"kind":"person","name":"Morrell Martha","position":1,"cik":"0001855616","reported_name":"Morrell Martha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-02-07T00:16:43.000Z","date":"2024-02-05","kind":"sale","planned":false,"acquired":false,"shares":3446,"price":15.1707,"value":52278.2322,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.00 to $15.285, inclusive. The\nreporting person undertakes to provide the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4."}],"balance_after":77762,"source":{"system":"sec-edgar","filing":"0001209191-24-002942","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1855616/000120919124002942/doc4.xml","form_type":"4"}},{"id":1656961,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":18764,"kind":"person","name":"Morrell Martha","position":1,"cik":"0001855616","reported_name":"Morrell Martha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-02-07T00:16:43.000Z","date":"2024-02-02","kind":"sale","planned":false,"acquired":false,"shares":14143,"price":15.0691,"value":213122.2813,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.00 to $15.19, inclusive. The reporting person undertakes to provide the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":81208,"source":{"system":"sec-edgar","filing":"0001209191-24-002942","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855616/000120919124002942/doc4.xml","form_type":"4"}},{"id":1664055,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":18764,"kind":"person","name":"Morrell Martha","position":1,"cik":"0001855616","reported_name":"Morrell Martha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-02-02T02:47:32.000Z","date":"2024-02-01","kind":"sale","planned":false,"acquired":false,"shares":663,"price":15.0393,"value":9971.0559,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.00 to $15.08, inclusive. The reporting person undertakes to provide the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (4) to this Form 4."}],"balance_after":95351,"source":{"system":"sec-edgar","filing":"0001209191-24-002596","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1855616/000120919124002596/doc4.xml","form_type":"4"}},{"id":1664054,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":18764,"kind":"person","name":"Morrell Martha","position":1,"cik":"0001855616","reported_name":"Morrell Martha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-02-02T02:47:32.000Z","date":"2024-01-31","kind":"sale","planned":false,"acquired":false,"shares":1923,"price":15.0752,"value":28989.6096,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.00 to $15.125, inclusive. The\nreporting person undertakes to provide the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4."}],"balance_after":96014,"source":{"system":"sec-edgar","filing":"0001209191-24-002596","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1855616/000120919124002596/doc4.xml","form_type":"4"}},{"id":1664053,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":18764,"kind":"person","name":"Morrell Martha","position":1,"cik":"0001855616","reported_name":"Morrell Martha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-02-02T02:47:32.000Z","date":"2024-01-30","kind":"sale","planned":false,"acquired":false,"shares":11262,"price":15.0954,"value":170004.3948,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.00 to $15.165, inclusive. The reporting person undertakes to provide the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":97937,"source":{"system":"sec-edgar","filing":"0001209191-24-002596","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855616/000120919124002596/doc4.xml","form_type":"4"}},{"id":1669757,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":18764,"kind":"person","name":"Morrell Martha","position":1,"cik":"0001855616","reported_name":"Morrell Martha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-01-26T23:04:15.000Z","date":"2024-01-25","kind":"sale","planned":false,"acquired":false,"shares":1,"price":15,"value":15.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":109199,"source":{"system":"sec-edgar","filing":"0001209191-24-002322","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1855616/000120919124002322/doc4.xml","form_type":"4"}},{"id":1669756,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":18764,"kind":"person","name":"Morrell Martha","position":1,"cik":"0001855616","reported_name":"Morrell Martha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-01-26T23:04:15.000Z","date":"2024-01-24","kind":"sale","planned":false,"acquired":false,"shares":827,"price":15.025,"value":12425.675,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.00 to $15.06, inclusive. The reporting person undertakes to provide the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":109200,"source":{"system":"sec-edgar","filing":"0001209191-24-002322","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855616/000120919124002322/doc4.xml","form_type":"4"}},{"id":1698810,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":18764,"kind":"person","name":"Morrell Martha","position":1,"cik":"0001855616","reported_name":"Morrell Martha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-12-28T22:47:30.000Z","date":"2023-12-27","kind":"sale","planned":false,"acquired":false,"shares":13300,"price":10.1239,"value":134647.87,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.00 to $10.18, inclusive. The reporting person undertakes to provide the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":110027,"source":{"system":"sec-edgar","filing":"0001209191-23-059946","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1855616/000120919123059946/doc4.xml","form_type":"4"}},{"id":1698809,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":18764,"kind":"person","name":"Morrell Martha","position":1,"cik":"0001855616","reported_name":"Morrell Martha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-12-28T22:47:30.000Z","date":"2023-12-26","kind":"sale","planned":false,"acquired":false,"shares":102,"price":10,"value":1020.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":123327,"source":{"system":"sec-edgar","filing":"0001209191-23-059946","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855616/000120919123059946/doc4.xml","form_type":"4"}},{"id":1701064,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":18764,"kind":"person","name":"Morrell Martha","position":1,"cik":"0001855616","reported_name":"Morrell Martha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-12-22T21:21:59.000Z","date":"2023-12-20","kind":"sale","planned":false,"acquired":false,"shares":2730,"price":10.1448,"value":27695.304,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.00 to $10.27, inclusive. The reporting person undertakes to provide the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":123429,"source":{"system":"sec-edgar","filing":"0001209191-23-059564","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855616/000120919123059564/doc4.xml","form_type":"4"}},{"id":1719169,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":18764,"kind":"person","name":"Morrell Martha","position":1,"cik":"0001855616","reported_name":"Morrell Martha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-12-07T21:07:01.000Z","date":"2023-12-06","kind":"sale","planned":false,"acquired":false,"shares":11005,"price":8.1575,"value":89773.2875,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.05 to $8.265, inclusive. The reporting person undertakes to provide the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":126159,"source":{"system":"sec-edgar","filing":"0001209191-23-057715","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855616/000120919123057715/doc4.xml","form_type":"4"}},{"id":2000210,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":18764,"kind":"person","name":"Morrell Martha","position":1,"cik":"0001855616","reported_name":"Morrell Martha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-02-23T00:39:38.000Z","date":"2023-02-20","kind":"grant","acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each share is represented by a restricted stock unit (\"RSU\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. 25% of the RSUs vest on February 20, 2024 and the remaining RSUs vest in eight (8) equal quarterly installments thereafter."}],"balance_after":137164,"source":{"system":"sec-edgar","filing":"0001209191-23-011946","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855616/000120919123011946/doc4.xml","form_type":"4"}},{"id":2139317,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":18764,"kind":"person","name":"Morrell Martha","position":1,"cik":"0001855616","reported_name":"Morrell Martha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-10-11T20:09:21.000Z","date":"2022-10-07","kind":"exercise","acquired":false,"shares":384,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option are fully vested."}],"balance_after":0,"derivative":{"exercise_price":0.026,"expiration_date":"2023-03-08","underlying":"Common Stock","underlying_shares":384},"source":{"system":"sec-edgar","filing":"0001209191-22-053273","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1855616/000120919122053273/doc4.xml","form_type":"4"}},{"id":2139316,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":18764,"kind":"person","name":"Morrell Martha","position":1,"cik":"0001855616","reported_name":"Morrell Martha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-10-11T20:09:21.000Z","date":"2022-10-07","kind":"exercise","acquired":false,"shares":192,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option are fully vested."}],"balance_after":0,"derivative":{"exercise_price":0.026,"expiration_date":"2022-11-13","underlying":"Common Stock","underlying_shares":192},"source":{"system":"sec-edgar","filing":"0001209191-22-053273","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1855616/000120919122053273/doc4.xml","form_type":"4"}},{"id":2139315,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":18764,"kind":"person","name":"Morrell Martha","position":1,"cik":"0001855616","reported_name":"Morrell Martha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-10-11T20:09:21.000Z","date":"2022-10-07","kind":"exercise","acquired":true,"shares":384,"price":0.026,"value":9.984,"ownership":{"direct":true},"balance_after":57164,"source":{"system":"sec-edgar","filing":"0001209191-22-053273","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1855616/000120919122053273/doc4.xml","form_type":"4"}},{"id":2139314,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":18764,"kind":"person","name":"Morrell Martha","position":1,"cik":"0001855616","reported_name":"Morrell Martha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-10-11T20:09:21.000Z","date":"2022-10-07","kind":"exercise","acquired":true,"shares":192,"price":0.026,"value":4.992,"ownership":{"direct":true},"balance_after":56780,"source":{"system":"sec-edgar","filing":"0001209191-22-053273","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855616/000120919122053273/doc4.xml","form_type":"4"}},{"id":2348247,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":18764,"kind":"person","name":"Morrell Martha","position":1,"cik":"0001855616","reported_name":"Morrell Martha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-08T01:06:03.000Z","date":"2022-03-03","kind":"grant","acquired":true,"shares":93530,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to the option vest on March 3, 2023. The remaining shares subject to the option vest in thirty six (36) equal consecutive monthly installments thereafter. The option is early exercisable."}],"balance_after":93530,"derivative":{"exercise_price":8.15,"exercise_date":"2022-03-03","expiration_date":"2032-03-02","underlying":"Common Stock","underlying_shares":93530},"source":{"system":"sec-edgar","filing":"0001209191-22-016874","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1855616/000120919122016874/doc4.xml","form_type":"4"}},{"id":2348246,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":18764,"kind":"person","name":"Morrell Martha","position":1,"cik":"0001855616","reported_name":"Morrell Martha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-03-08T01:06:03.000Z","date":"2022-03-03","kind":"grant","acquired":true,"shares":46760,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each share is represented by a restricted stock unit (\"RSU\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. 25% of the RSUs vest on March 3, 2023 and the remaining RSUs vest in twelve (12) equal quarterly installments thereafter."}],"balance_after":56588,"source":{"system":"sec-edgar","filing":"0001209191-22-016874","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855616/000120919122016874/doc4.xml","form_type":"4"}},{"id":2652076,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":18764,"kind":"person","name":"Morrell Martha","position":1,"cik":"0001855616","reported_name":"Morrell Martha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-29T22:12:08.000Z","date":"2021-06-04","kind":"grant","acquired":true,"shares":16620,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to the option vest on April 22, 2022. The remaining shares subject to the option vest in twelve (12) equal quarterly installments thereafter.  The option is early exercisable."}],"balance_after":16620,"derivative":{"exercise_price":21.67,"exercise_date":"2021-06-04","expiration_date":"2031-06-03","underlying":"Common Stock","underlying_shares":16620},"source":{"system":"sec-edgar","filing":"0001209191-21-043742","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1855616/000120919121043742/doc4a.xml","form_type":"4/A","original_submission_date":"2021-06-08"}},{"id":2652075,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":18764,"kind":"person","name":"Morrell Martha","position":1,"cik":"0001855616","reported_name":"Morrell Martha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical officer"}}],"security":"Common Stock","published_at":"2021-06-29T22:12:08.000Z","date":"2021-06-04","kind":"grant","acquired":true,"shares":8310,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each share is represented by a restricted stock unit (\"RSU\").  Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. 25% of the RSUs vest on April 22, 2022 and the remaining RSUs vest in twelve (12) equal quarterly installments thereafter."}],"balance_after":9828,"source":{"system":"sec-edgar","filing":"0001209191-21-043742","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855616/000120919121043742/doc4a.xml","form_type":"4/A","original_submission_date":"2021-06-08"}},{"id":2677888,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":18764,"kind":"person","name":"Morrell Martha","position":1,"cik":"0001855616","reported_name":"Morrell Martha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-08T22:05:08.000Z","date":"2021-06-04","kind":"grant","acquired":true,"shares":16363,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to the option vest on April 22, 2022. The remaining shares subject to the option vest in twelve (12) equal quarterly installments thereafter.  The option is early exercisable."}],"balance_after":16363,"derivative":{"exercise_price":21.67,"exercise_date":"2021-06-04","expiration_date":"2031-06-03","underlying":"Common Stock","underlying_shares":16363},"source":{"system":"sec-edgar","filing":"0001209191-21-038996","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1855616/000120919121038996/doc4.xml","form_type":"4"}},{"id":2677887,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":18764,"kind":"person","name":"Morrell Martha","position":1,"cik":"0001855616","reported_name":"Morrell Martha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical officer"}}],"security":"Common Stock","published_at":"2021-06-08T22:05:08.000Z","date":"2021-06-04","kind":"grant","acquired":true,"shares":8181,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each share is represented by a restricted stock unit (\"RSU\").  Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. 25% of the RSUs vest on April 22, 2022 and the remaining RSUs vest in twelve (12) equal quarterly installments thereafter."}],"balance_after":9699,"source":{"system":"sec-edgar","filing":"0001209191-21-038996","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855616/000120919121038996/doc4.xml","form_type":"4"}}]}